Novartis

Portland, Oregon 97239

0 studies enrolling now · 2 studies all time

What they study most

Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy, Renal Transplantation

Studies at this site

• Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis — Completed
• A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms — Stopped early